tirzepatide approval vs. Semaglutide: What You Should Know Lilly's Zepbound (aka tirzepatide) Lands

How This Category Compares to Other Access Models Consumers exploring GLP-1 weight loss options in 2026 generally encounter three distinct access models, each with different regulatory status, cost structures, and clinical considerations

There is one peculiarity with Mounjaro: because the weight loss can carry on for more than 72 weeks, the phase sometimes drags on longer than with classic acute telogen effluvium

Thyroid C-Cell Tumors: In rats, Mounjaro injection caused a dose-dependent and treatment-duration-dependent increase in thyroid C-cell tumors

Oral Semaglutide Dosage: How to Take It Understanding the correct usage of the semaglutide oral dose for weight loss is crucial to its success